Bonick Martin 4

What Happened Martin Bonick, President, CEO and Director of Ardent Health, was granted 134,615 restricted stock units (RSUs) on April 1, 2026 (acquisition code A). To cover tax withholding on vested RSUs, 8,026 shares were withheld/disposed on March 31, 2026 at $8.56 each ($68,703) and 10,952 shares were withheld/disposed on April 1, 2026 at $8.67 each ($94,954). The RSUs were granted with a $0 exercise price; using the April 1 closing price ($8.67) the grant’s approximate market value is about $1.17 million. The disposals were tax-withholding transactions (code F), which are routine and not open-market sales indicating a change in investment view.

Key Details

• Transaction dates and prices:
  • 2026-03-31: 8,026 shares withheld at $8.56 → $68,703 (tax withholding, code F)
  • 2026-04-01: 10,952 shares withheld at $8.67 → $94,954 (tax withholding, code F)
  • 2026-04-01: 134,615 RSUs granted at $0 → recorded as acquisition (code A); market value ≈ $1.17M at $8.67 close
• Total shares withheld for taxes: 18,978; total withheld value: $163,657
• Shares owned after transaction: Not specified in the provided filing data
• Footnotes:
  • F1: Withheld shares were used to pay taxes upon RSU vesting in accordance with Rule 16b-3
  • F2/F3: Prices reflect closing prices on 3/31/2026 and 4/1/2026
  • F4: RSUs vest in three substantially equal installments on each anniversary of April 1, 2026, subject to continued service
• Filing: Report filed April 2, 2026 (no lateness flag provided in the supplied information)

Context This filing reflects a grant of RSUs and routine tax-withholding disposals (a cashless withholding approach), not open-market purchases or discretionary sales. The RSU grant is an award (no cash purchase) and vests over three years per the footnote; the withheld shares simply satisfied tax obligations upon vesting. Such withholding transactions are common and generally administrative rather than a direct signal of insider sentiment.